SHANGHAI CHEMPARTNER

ShangPharma, the holding company of Shanghai ChemPartner Co. Ltd. and Shanghai ChemExplorer Co. Ltd., is one of the largest CROs (Contract Research Organizations) in China and provides a comprehensive portfolio of services to global pharmaceutical and biotech companies. We have a A team of skilled scientists and a problem-solving culture that enable us to respond to our clients toughest challenges. Headquartered in Zhangjiang Hi-Tech Park, Pudong New Area of ​​Shanghai, ShangPharma currently has a staff of more than 1,600 scientists in virtually every discipline. Over 40% of our scientific staff have post-graduate degrees and all of our top scientific leaders have U.S. and/or European industrial experience in major international pharmaceutical and biotechnology companies. ShangPharma---- Meeting Your DemandsWith a commitment to meeting your demands, ShangPharma offers unparalleled expertise, experience, and results. ShangPharma understands the rapidly changing challenges which face pharmaceutical and biotechnology companies of all sizes in developing innovative drugs. Our CRO business is built around your demands, our integrated services are designed to help bring your new products to market as safely, efficiently, and cost-effectively as possible. Shanghua Pharmaceutical R&D Services Group (SHP) owns four subsidiaries: Shanghai Ruizhi, Shanghai Pioneer, Shanghai Kaihui and Chengdu Kaihui. In October 2007, TPG invested more than US$30 million in Shanghua Pharmaceutical. The company is currently mainly engaged in providing domestic and foreign customers with scientific research services in the fields of combinatorial chemistry, medicinal chemistry, synthetic chemistry, etc.; quality testing of chemical and pharmaceutical products; introduction, incubation and industrialization of medical and biotechnology. On October 19, 2010, Shanghua Pharmaceutical was listed on the New York Stock Exchange. Smart Chemistry was established in April 2003 in the Biomedical Base of Shanghai Zhangjiang Hi-Tech Park, the Pharmaceutical Valley of China. It currently has a 13,000 square meter chemical laboratory with advanced scientific research equipment and international leading standards. The company has assembled an elite team of more than 600 people from home and abroad. The company's scientific research management team is composed of PhDs with more than ten years of overseas work experience. The researchers are all senior talents who have been engaged in research and development in large enterprise groups and scientific research institutes for many years, and have rich scientific research experience and innovation awareness. With its advanced technology advantages, competitive talent advantages, and perfect customer service management, Smart Chemistry has launched multi-level and fruitful scientific research cooperation with many of the world's top 20 biological and pharmaceutical companies, with remarkable results. Pioneer Chemicals was established in June 2002 in China's Pharmaceutical Valley - the biomedical base of Zhangjiang High-tech Park in Shanghai. By signing a long-term cooperation agreement with Eli Lilly and Company, one of the world's top 500 companies, both parties jointly established Eli Lilly and Company in Zhangjiang. In China's largest collaborative research base - Pioneer Chemistry. This innovative cooperation model has accumulated rich research experience for the company, cultivated a high-quality scientific research team and a high-efficiency scientific research platform. The company has reached a laboratory area of ​​more than 13,000 square meters and a R&D and management team of more than 300 people in a short period of time. Currently, Pioneer Chemical's R&D projects have been integrated into Eli Lilly's global drug R&D system, thereby promoting China's participation in the development of global drug R&D. Shanghai Kaihui Pharmaceutical Chemical Co., Ltd. is a comprehensive enterprise specializing in the research, development, production and sales of pharmaceutical chemicals and pharmaceutical intermediates, with a factory base of nearly 3,000 square meters. A new 60,000-square-meter factory with advanced equipment and complete supporting facilities will be completed and put into use in 2009. The company is mainly engaged in the research and development and process optimization of new high value-added pharmaceutical intermediates, fine chemicals and API synthesis. It is especially committed to natural products, special reagents required for the research and development of new drugs, and the amplification and optimization of various sugar compounds. Production.